Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback